Gloria Woo

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. pmc How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada
    Claire de Oliveira
    University Health Network, Toronto, ON, Canada
    BMC Health Serv Res 12:281. 2012
  2. pmc Health state utilities and quality of life in patients with hepatitis B
    Gloria Woo
    Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    Can J Gastroenterol 26:445-51. 2012
  3. doi request reprint Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses
    Gloria Woo
    Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Ontario, Canada
    Gastroenterology 139:1218-29. 2010

Collaborators

Detail Information

Publications3

  1. pmc How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada
    Claire de Oliveira
    University Health Network, Toronto, ON, Canada
    BMC Health Serv Res 12:281. 2012
    ..Our objective was to estimate the magnitude of expenditures on CVD research for the public and charitable (not-for profit) sectors in Canada between 1975 and 2005...
  2. pmc Health state utilities and quality of life in patients with hepatitis B
    Gloria Woo
    Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    Can J Gastroenterol 26:445-51. 2012
    ..The effect of chronic hepatitis B (CHB) infection on health-related quality of life (HRQoL) and health state utilities has not been well characterized...
  3. doi request reprint Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses
    Gloria Woo
    Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Ontario, Canada
    Gastroenterology 139:1218-29. 2010
    ..We evaluated the relative efficacies of the first 12 months of CHB treatments...